Tandem Diabetes Care Inc (FRA:TD5A)
€ 46.5 -0.61 (-1.29%) Market Cap: 3.09 Bil Enterprise Value: 3.10 Bil PE Ratio: 0 PB Ratio: 13.74 GF Score: 78/100

Tandem Diabetes Care Inc at Stifel Virtual Healthcare Conference Transcript

Nov 17, 2020 / 09:40PM GMT
Release Date Price: €80.3 (-5.68%)
Mathew Justin Blackman
Stifel, Nicolaus & Company, Incorporated, Research Division - Analyst

All right. Good afternoon, everyone. Welcome to the -- I think this is the final session for the second day of the 2020 Virtual Stifel Health Care Conference. Thank you for joining us. And closing out our day, we're thrilled to host a session with Tandem Diabetes, the leader today in the automated insulin delivery revolution we're seeing in diabetes technology. We're nearly a year into the launch of Control-IQ, which is fair to say the most advanced, highest functioning insulin delivery system on the market today. And it's evidenced by a really remarkable adoption trajectory over the last several quarters and all that despite a pandemic.

And so we're going to clearly spend some time on that. We have joining us today Leigh Vosseller, Executive VP and CFO; and Susan Morrison, Chief Administrative Officer and Executive Vice President. Thanks so much for participating once again this year.

And just a reminder to everyone in the virtual audience, if you have questions, just type them in the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot